Home
About
Portfolio
Biotherapy for Cancer
CAR-T Australia
CAR-T Clinics
Anti-Ageing and Longevity
Biotech Startups
Investment Funds
On the Frontline
For A Cure Foundation
The Power of Stem Cell Advocacy
Celebrity Page
Corporate Support
News
Contact
Car-T
Home
News
Car-T
November 14, 2017
Forbes: Gilead-Kite: A Breakthrough. A $12 Billion Deal.
Gilead Sciences, the leading maker of drugs for HIV and hepatitis C, made an expensive and gutsy move into the cutting edge of cancer treatment this […]
